Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Supplement shows promise for diabetes and malnutrition

NCT ID NCT06866366

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a special nutritional drink called Resource Diabet Plus can improve blood sugar and cholesterol levels in people with type 2 diabetes who are malnourished or at risk of malnutrition. Researchers reviewed medical records of 59 patients in Spain who took the supplement for at least 24 weeks. The goal was to see if it helped them achieve better metabolic control in real-world settings.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Resource Diabet Plus (a nutritional supplement)
What this could lead to
If successful, this could show that a simple nutritional supplement helps manage blood sugar and cholesterol in people with type 2 diabetes who are also malnourished.
What could go wrong
This is a small, completed study with only 59 participants, and it looks back at medical records rather than testing the supplement in a controlled way. Results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

59 people

The number who actually took part.

Started

Apr 2025

Finished

Jul 2025

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Type 2 diabetic patient with malnutrition or at risk of malnutrition, treated for it in hospitals of the national network who have been prescribed 1-2 bottles/day of Resource® Diabet Plus

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients ≥ 18 years. * Outpatients or hospitalised patients, at discharge with a diagnosis of type 2 Diabetes. * Patients at risk of malnutrition detected by validated screening tools or with DRM diagnosed by GLIM criteria. * Patients who have been prescribed 1-2 bottles/day of Resource® Diabet Plus following the conditions of use of its technical data sheet, in the last 2 years, with at least 24 weeks of evolution recorded in the clinical history. * Patients who have Hb1Ac data in the medical record on the index date and during evolution. Exclusion Criteria: * Pregnant or breastfeeding women. * Patients who required any other type of nutritional supplementation during the study period (parenteral/enteral). * Patients with severe renal insufficiency (glomerular filtration rate \< 30mL/min/1.73m2) at the time of selection.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus type 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Clínico Universitario Virgen de la Arrixaca

    Murcia, Spain

  • Hospital Universitario Insular de Gran Canaria

    Las Palmas de Gran Canaria, Spain

  • Hospital Universitario Nuestra Señora de la Candelaria

    Santa Cruz de Tenerife, Spain

  • Hospital Universitario Virgen Macarena

    Seville, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.